Metraipolis › archive › dc_e68d587491a7
Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41394847
- DOI
- 10.3389/fimmu.2025.1686570
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:11:40.107Z
- SHA-256 of the archived text
e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15- Stable URL of this page
https://metraipolis.com/documento/dc_e68d587491a7
How to cite
Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847 — Europe PMC (en), https://europepmc.org/article/MED/41394847 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e68d587491a7 (Metraipolis archive dc_e68d587491a7, sha256 e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15)
BibTeX
@misc{dce68d587491a7,
title = {Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a… — Europe PMC PMID:41394847},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41394847},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e68d587491a7; sha256 e1396f9a7c634063d3a74d20cc67c6be9f783a03ae768d523c342a61026b4f15},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41394847. Agents can read the archived copy with the MCP tool read_document.